The roles of lipid in anti-biofilm efficacy of lipid-polymer hybrid nanoparticles encapsulating antibiotics

Colloids and Surfaces A: Physicochemical and Engineering Aspects

Volumn 389, Issue 1-3, 2011, Pages 158-165

  Cheow, Wean Sin ^a   Chang, Matthew Wook ^a   Hadinoto, Kunn ^a  

^a Nanyang Technological University   (Singapore)

Author keywords

Antibiotics; Biofilm; Bronchiectasis; Hybrid nanoparticles; Lipids; Pseudomonas aeruginosa

Indexed keywords

ANTIBIOTICS; BACTERIA; BIOFILMS; LIPOSOMES; PHOSPHOLIPIDS; POLYMERS; SUSPENSIONS (FLUIDS);

ANTI-BACTERIAL ACTIVITY; ANTI-BIOFILM; ANTIBACTERIAL EFFICACY; ANTIBIOTIC ACTIVITY; ANTIBIOTIC RELEASE; AQUEOUS SUSPENSIONS; BIOFILM CELLS; BIOFILM INFECTIONS; BIOFILM MATRIX; BRONCHIECTASIS; DELIVERY VEHICLE; FOLLOW-UP STUDIES; HIGH AFFINITY; HYBRID NANOPARTICLE; HYBRID NANOPARTICLES; IN-VITRO; LEVOFLOXACIN; LIPID INCLUSIONS; PHARMACEUTICAL DOSAGE FORMS; PHOSPHATIDYLCHOLINE; PLANKTONIC CELLS; POLY(LACTIC-CO-GLYCOLIC ACID); POLYMERIC NANOPARTICLES; PSEUDOMONAS AERUGINOSA; RELEASE RATE;

NANOPARTICLES;

LEVOFLOXACIN; LIPID; NANOPARTICLE; PHOSPHATIDYLCHOLINE; POLYGLACTIN;

ANTIBACTERIAL ACTIVITY; ARTICLE; BIOFILM; CONTROLLED STUDY; DRUG EFFICACY; DRUG RELEASE; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA;

EID: 80054082800     PISSN: 09277757     EISSN: 18734359     Source Type: Journal    
DOI: 10.1016/j.colsurfa.2011.08.035     Document Type: Article

References (23)

1. Davies D. Understanding biofilm resistance to antibacterial agents. Nat. Rev. Drug Discov. 2003, 2:114-122.
2. Hoiby N., Bjarnsholt T., Givskov M., Molin S., Ciofu O. Antibiotic resistance of bacterial biofilms. Int. J. Antimicrob. Agents 2010, 35:322-332.
3. Suk J.S., Lai S.K., Wang Y.Y., Ensign L.M., Zeitlin P.L., Boyle M.P., Hanes J. The penetration of fresh undiluted sputum expectorated by cystic fibrosis patients by non-adhesive polymer nanoparticles. Biomaterials 2009, 30:2591-2597.
4. Halwani M., Hebert S., Suntres Z.E., Lafrenie R.M., Azghani A.O., Omri A. Bismuth-thiol incorporation enhances biological activities of liposomal tobramycin against bacterial biofilm and quorum sensing molecules production by Pseudomonas aeruginosa. Int. J. Pharm. 2009, 373:141-146.
5. Meers P., Neville M., Malinin V., Scotto A.W., Sardaryan G., Kurumunda R., Mackinson C., James G., Fisher S., Perkins W.R. Biofilm penetration, triggered release and in vivo activity of inhaled liposomal amikacin in chronic Pseudomonas aeruginosa lung infections. J. Antimicrob. Chemoth. 2008, 61:859-868.
6. Mugabe C., Halwani M., Azghani A.O., Lafrenie R.M., Omri A. Mechanism of enhanced activity of liposome-entrapped aminoglycosides against resistant strains of Pseudomonas aeruginosa. Antimicrob. Agents Ch. 2006, 50:2016-2022.
7. Cheow W., Chang M., Hadinoto K. Antibacterial efficacy of inhalable levofloxacin-loaded polymeric nanoparticles against E. coli biofilm cells: the effect of antibiotic release profile. Pharm. Res. 2010, 27:1597-1609.
8. Sanders N.N., De Smedt S.C., Van Rompaey E., Simoens P., De Baets F., Demeester J. Cystic fibrosis sputum - A barrier to the transport of nanospheres. Am. J. Resp. Crit. Care 2000, 162:1905-1911.
9. Chono S., Tanino T., Seki T., Morimoto K. Influence of particle size on drug delivery to rat alveolar macrophages following pulmonary administration of ciprofloxacin incorporated into liposomes. J. Drug Target. 2006, 14:557-566.
10. Robinson A.M., Bannister M., Creeth J.E., Jones M.N. The interaction of phospholipid liposomes with mixed bacterial biofilms and their use in the delivery of bactericide. Colloid Surf. A 2001, 186:43-53.
11. Vyas S.P., Sihorkar V., Jain S. Mannosylated liposomes for bio-film targeting. Int. J. Pharm. 2007, 330:6-13.
12. Ahmed K., Gribbon P., Jonest M.N. The application of confocal microscopy to the study of liposome adsorption onto bacterial biofilms. J. Liposome Res. 2002, 12:285-300.
13. Drulis-Kawa Z., Dorotkiewicz-Jach A. Liposomes as delivery systems for antibiotics. Int. J. Pharm. 2010, 387:187-198.
14. Labiris N.R.C., Holbrook A.M., Chrystyn H., Macleod S.M., Newhouse M.T. Dry powder versus intravenous and nebulized gentamicin in cystic fibrosis and bronchiectasis - A pilot study. Am. J. Resp. Crit. Care 1999, 160:1711-1716.
15. Ishida H., Ishida Y., Kurosaka Y., Otani T., Sato K., Kobayashi H. In vitro and in vivo activities of levofloxacin against biofilm-producing Pseudomonas aeruginosa. Antimicrob. Agents Ch. 1998, 42:1641-1645.
16. Stapper A.P., Narasimhan G., Ohman D.E., Barakat J., Hentzer M., Molin S., Kharazmi A., Hoiby N., Mathee K. Alginate production affects Pseudomonas aeruginosa biofilm development and architecture, but is not essential for biofilm formation. J. Med. Microbiol. 2004, 53:679-690.
17. Cheow W.S., Hadinoto K. Enhancing encapsulation efficiency of highly water-soluble antibiotic in poly(lactic-co-glycolic acid) nanoparticles: modifications of standard nanoparticle preparation methods. Colloid Surf. A 2010, 370:79-86.
18. Hadinoto K., Cheow W.S. Hollow spherical nanoparticulate aggregates as potential ultrasound contrast agent: shell thickness characterization. Drug Dev. Ind. Pharm. 2009, 35:1167-1179.
19. Kho K., Hadinoto K. Aqueous re-dispersibility characterization of spray-dried hollow spherical silica nano-aggregates. Powder Technol. 2010, 198:354-363.
20. Ghannoum M., O'Toole G. Microbial Biofilms 2004, ASM Press.
21. Hickey A.J. Pharmaceutical Inhalation Aerosol Technology 2004, Marcel Dekker.
22. Cohen S., Bano M.C., Chow M., Langer R. Lipid alginate interactions render changes in phospholipid-bilayer permeability. Acta Bioch. Bioph. Sin. 1991, 1063:95-102.
23. Dhoot N.O., Wheatley M.A. Microencapsulated liposomes in controlled drug delivery: strategies to modulate drug release and eliminate the burst effect. J. Pharm. Sci. 2003, 92:679-689.